Advertisement

Check-Cap Ltd. CHEK

Set alert

Price alert · CHEK

All alert types
1.86 0.00 0.00%

As of May 21, 9:30 AM ET

1.77 Day range 1.86
0.56 52-week range 3.45
YTD
+87.88%
1 year
+130.20%
Open
1.80
Prev close
1.86
Mkt cap
13.16M
Vol
39.37K
Avg vol
20.07K
EPS
-3.00
P/E
0.00
Div yield
0.00%
More statistics
Low
1.77
High
1.86
Forward P/E
-0.87
Beta
0.18
Short ratio
0.43
Inst. own
0.23%
Dividend
0.00
Ex-div date
Earnings
Dec 23, 2024
50-d avg
0.96552
200-d avg
1.77
1y target
0.00

2Y chart

Chart tools
Interval
CHEK two-year price chart0.561.282.002.733.45Dec 23Apr 24Sep 24Feb 25Jul 25Dec 25

Key statistics

Market cap
13.16M
Enterprise value
-21.31M
Trailing P/E
0.00
Forward P/E
-0.87
PEG ratio
0.00
Price / sales
0.00
Price / book
0.56
EPS (TTM)
-3.00
Beta
0.18
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-12.00M
Total cash
24.77M
Total debt
0
Return on equity
-54.06%
Shares outstanding
5.85M
Short % of float
0.18%
50-day average
0.96552
200-day average
1.77

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Dec 23, 2024

Expected Dec 23, 2024. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
CHEK Revenue — quarterly 0
2020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 2023
CHEK Net income — quarterly -3.66M
2020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 2023
CHEK EPS — quarterly -0.62
2020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 2023

Earnings

CHEK recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 23, 2024Sep 1, 20240.00———
Oct 4, 2024Jun 1, 20240.00———
Jul 4, 2024Mar 1, 2024-0.17———
May 15, 2024Dec 1, 20230.00-0.62——
Nov 27, 2023Sep 1, 2023-0.30-0.44-0.14-46.67%
Aug 4, 2023Jun 1, 2023-0.45-0.95-0.50-111.11%

Upgrades / downgrades

CHEK analyst upgrades and downgrades
DateFirmActionFromTo
Jun 7, 2023HC Wainwright & Co.downBuyNeutral
May 15, 2023HC Wainwright & Co.reitBuyBuy
Apr 5, 2023HC Wainwright & Co.reit—Buy
Aug 9, 2021HC Wainwright & Co.main—Buy
Mar 17, 2021Dawson JamesdownBuyNeutral
Mar 16, 2021HC Wainwright & Co.main—Buy

About Check-Cap Ltd.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Sector
Healthcare
Industry
Diagnostics & Research
Country
Israel

News

Your note

Sign in to keep a note on CHEK — it syncs with the Stock Master app.

Institution ownership

CHEK institution ownership
Holder% heldSharesValueReported
UBS Group AG0.07%4,1029.23KSep 29, 2024
JP Morgan Chase & Company0.03%1,5003.38KSep 29, 2024
Osaic Holdings Inc0.03%1,6223.65KSep 29, 2024
Morgan Stanley0.03%1,6623.74KSep 29, 2024
IFP Advisors, Inc0.01%5001.13KJun 29, 2024
Bank of America Corporation0.01%300675Sep 29, 2024

Fund ownership

CHEK fund ownership
Holder% heldSharesValueReported
DFA U.S. Micro Cap Series0.15%8,95820.16KJul 30, 2024
Fidelity NASDAQ Composite Index Fund0.05%2,9326.60KOct 30, 2024
Advertisement